[시장보고서]미국의 세포배양 보충제 시장 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 용도별, 최종 용도별, 부문 예측(2025-2033년)

미국의 세포배양 보충제 시장 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 용도별, 최종 용도별, 부문 예측(2025-2033년)

U.S. Cell Culture Supplements Market Size, Share & Trends Analysis Report By Product Type, By Application (Biopharmaceutical Manufacturing, Cell & Gene Therapy, Drug Discovery), By End Use, And Segment Forecasts, 2025 - 2033

상품코드 : 1813860

리서치사 : Grand View Research

발행일 : 2025년 08월

페이지 정보 : 영문 90 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,545,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 9,981,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 12,853,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

미국의 세포배양 보충제 시장 동향 :

미국의 세포 배양 보충제 시장 규모는 2024년 8억 1,330만 달러로 평가되었고, 바이오 의약품 수요 증가, 세포 배양 기술 발전, 재생 의학 및 세포 기반 치료 분야의 연구 활동 확대 등을 배경으로 2025-2033년 연평균 12.76% 성장하여 2033년에는 23억 480만 달러에 달할 것으로 예측됩니다.

기업/경쟁 분류
전략 매핑
기업 시장 현황 분석, 2024년
기업 개요/상장기업
- Merck KGaA
- Thermo Fisher Scientific Inc.
- HiMedia Laboratories
- Danaher
- Sartorius AG
- Corning Inc.
- R&D Systems(Bio-Techne)
- STEMCELL Technologies
- Repligen Corporation
- Proteintech Group, Inc

LSH

영문 목차

영문목차

U.S. Cell Culture Supplements Market Trends:

The U.S. cell culture supplements market size was valued at USD 813.3 million in 2024 and is anticipated to reach USD 2304.8 million by 2033, growing at a CAGR of 12.76% from 2025 to 2033, driven by increasing demand for biopharmaceuticals, advancements in cell culture technologies, and expanding research activities in regenerative medicine and cell-based therapies.

U.S. Cell Culture Supplements Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the U.S. cell culture supplements market on the basis of product type, application, and end use:

Product Type Outlook (Revenue, USD Million, 2021 - 2033)
- Serum-Based Supplements
- Protein-Based & Recombinant Supplements
- Chemically Defined Supplements
- Others
Application Outlook (Revenue, USD Million, 2021 - 2033)
- Biopharmaceutical Manufacturing
- Cell & Gene Therapy
- Drug Discovery
- Others
End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Cell Culture Media Manufacturers
- Pharmaceutical & Biotechnology Companies
- CDMOs/ CMOs & CROs
- Academic & Research Institutes

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Market Definitions
- 1.2.1. Product Type Segment
- 1.2.2. Application Segment
- 1.2.3. End Use Segment
1.3. Information Analysis
- 1.3.1. Market formulation & data visualization
1.4. Data Validation & Publishing
1.5. Information Procurement
- 1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
- 1.10.1. Objective 1
- 1.10.2. Objective 2

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape

Chapter 3. Cell Culture Supplements Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Growth of cell and gene therapy
  - 3.2.1.2. Rising biologics and biosimilars production
- 3.2.2. Market restraint analysis
  - 3.2.2.1. High cost of GMP-grade and specialty supplements
  - 3.2.2.2. Regulatory and standardization challenges
3.3. U.S. Cell Culture Supplements Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis

Chapter 4. U.S. Cell Culture Supplements Market: Product Type Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. U.S. Cell Culture Supplements Market Product Type Movement Analysis
4.3. U.S. Cell Culture Supplements Market Size & Trend Analysis, by Product Type, 2021 to 2033 (USD Million)
4.4. Serum-Based Supplements
- 4.4.1. Serum-Based Supplements Market Estimates and Forecasts 2021 to 2033 (USD Million)
4.5. Protein-Based & Recombinant Supplements
- 4.5.1. Protein-Based & Recombinant Supplements Market Estimates and Forecasts 2021 to 2033 (USD Million)
4.6. Chemically Defined Supplements
- 4.6.1. Kits & Reagents Market Estimates and Forecasts 2021 to 2033 (USD Million)
4.7. Others
- 4.7.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. Cell Culture Supplements Market: Application Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. U.S. Cell Culture Supplements Market Application Movement Analysis
5.3. U.S. Cell Culture Supplements Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
5.4. Biopharmaceutical Manufacturing
- 5.4.1. Biopharmaceuticals Manufacturing Market Estimates and Forecasts 2021 to 2033 (USD Million)
5.5. Cell & Gene Therapy
- 5.5.1. Cell & Gene Therapy Market Estimates and Forecasts 2021 to 2033 (USD Million)
5.6. Drug Discovery
- 5.6.1. Drug Discovery Market Estimates and Forecasts 2021 to 2033 (USD Million)
5.7. Others
- 5.7.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. Cell Culture Supplements Market: End Use Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. U.S. Cell Culture Supplements Market End Use Movement Analysis
6.3. U.S. Cell Culture Supplements Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
6.4. Cell Culture Media Manufacturers
- 6.4.1. Cell Culture Media Manufacturers Companies Market Estimates and Forecasts 2021 to 2033 (USD Million)
6.5. Pharmaceutical & Biotechnology Companies
- 6.5.1. Pharmaceuticals & Biotechnology Companies Market Estimates and Forecasts 2021 to 2033 (USD Million)
6.6. CDMOs/ CMOs & CROs
- 6.6.1. CDMOs/ CMOs & CROs Market Estimates and Forecasts 2021 to 2033 (USD Million)
6.7. Academic & Research Institutes
- 6.7.1. Academic & Research Institutes Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

7.1. Company/Competition Categorization
7.2. Strategy Mapping
7.3. Company Market Position Analysis, 2024
7.4. Company Profiles/Listing
- 7.4.1. Merck KGaA
  - 7.4.1.1. Company Overview
  - 7.4.1.2. Financial Performance
  - 7.4.1.3. Product/Service Benchmarking
  - 7.4.1.4. Strategic Initiatives
- 7.4.2. Thermo Fisher Scientific Inc.
  - 7.4.2.1. Company Overview
  - 7.4.2.2. Financial performance
  - 7.4.2.3. Product/Service Benchmarking
  - 7.4.2.4. Strategic Initiatives
- 7.4.3. HiMedia Laboratories
  - 7.4.3.1. Company Overview
  - 7.4.3.2. Financial Performance
  - 7.4.3.3. Product/Service Benchmarking
  - 7.4.3.4. Strategic Initiatives
- 7.4.4. Danaher
  - 7.4.4.1. Company Overview
  - 7.4.4.2. Financial Performance
  - 7.4.4.3. Product/Service Benchmarking
  - 7.4.4.4. Strategic Initiatives
- 7.4.5. Sartorius AG
  - 7.4.5.1. Company Overview
  - 7.4.5.2. Financial Performance
  - 7.4.5.3. Product/Service Benchmarking
  - 7.4.5.4. Strategic Initiatives
- 7.4.6. Corning Inc.
  - 7.4.6.1. Company Overview
  - 7.4.6.2. Financial Performance
  - 7.4.6.3. Product/Service Benchmarking
  - 7.4.6.4. Strategic Initiatives
- 7.4.7. R&D Systems (Bio-Techne)
  - 7.4.7.1. Company Overview
  - 7.4.7.2. Financial Performance
  - 7.4.7.3. Product/Service Benchmarking
  - 7.4.7.4. Strategic Initiatives
- 7.4.8. STEMCELL Technologies
  - 7.4.8.1. Company Overview
  - 7.4.8.2. Financial Performance
  - 7.4.8.3. Product/Service Benchmarking
  - 7.4.8.4. Strategic Initiatives
- 7.4.9. Repligen Corporation
  - 7.4.9.1. Company Overview
  - 7.4.9.2. Financial Performance
  - 7.4.9.3. Product/Service Benchmarking
  - 7.4.9.4. Strategic Initiatives
- 7.4.10. Proteintech Group, Inc
  - 7.4.10.1. Company Overview
  - 7.4.10.2. Financial Performance
  - 7.4.10.3. Product/Service Benchmarking
  - 7.4.10.4. Strategic Initiatives

한글목차

미국의 세포배양 보충제 시장 동향 :

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 세포배양 보충제 시장 변수, 동향, 범위

제4장 미국의 세포배양 보충제 시장 : 제품 유형 추정 및 동향 분석

제5장 미국의 세포배양 보충제 시장 : 용도 추정 및 동향 분석

제6장 미국의 세포배양 보충제 시장 : 최종 용도 추정 및 동향 분석

제7장 경쟁 구도